• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Nucleolar protein 6 (NOL6), Truncated

ACP11524

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP11524 Target NameNOL6
Target SynonymsNOL6; Nucleolar protein 6; Nucleolar RNA-associated protein; NrapFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9H6R4
Background Information
  • Uniprot Id

    Q9H6R4

  • Target Species

    Human

  • Target Name

    NOL6

  • Target Full Name

    Nucleolar protein 6

  • Target Subcellular Location

    Nucleus, nucleolus. Chromosome.

  • Target Protein Families

    NRAP family

  • Target Synonyms

    NOL6; Nucleolar protein 6; Nucleolar RNA-associated protein; Nrap

  • Target Background

    The nucleolus is a dense subnuclear membraneless organelle that assembles around clusters of rRNA genes and functions in ribosome biogenesis. This gene encodes a nucleolar RNA-associated protein that is highly conserved between species. RNase treatment of permeabilized cells indicates that the nucleolar localization is RNA dependent. Further studies suggest that the protein is associated with ribosome biogenesis through an interaction with pre-rRNA primary transcripts. Alternative splicing has been observed at this locus and two splice variants encoding distinct isoforms have been identified.

Inquire Recombinant Human Nucleolar protein 6 (NOL6), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification